Product Introduction

Glycomet GP 2mg Tablet is a combination oral anti-diabetic medication that contains Glimepiride and Metformin. It is primarily used to manage type 2 diabetes mellitus by lowering blood glucose levels through complementary mechanisms. This medicine helps enhance insulin secretion from the pancreas and reduces glucose production from the liver, making it effective for long-term diabetes management.

The tablet should be taken with meals to minimize gastrointestinal discomfort and to ensure optimal absorption. Consistent daily use, along with proper dietary control and regular exercise, is vital for effective glycemic control.

Uses of Glycomet GP 2mg Tablet

• Management of Type 2 Diabetes Mellitus

Benefits of This Medicine

This medicine combines the action of two powerful agents. Glimepiride helps the pancreas produce more insulin, while Metformin improves the body’s response to insulin and decreases sugar production in the liver. This dual action helps prevent complications of uncontrolled diabetes such as nerve damage, kidney disease, and vision problems.

Possible Side Effects

Most side effects are mild and subside as your body adjusts to the medication. However, consult your doctor if symptoms persist or worsen.

• Hypoglycemia (low blood sugar)
• Nausea or vomiting
• Abdominal pain
• Diarrhea
• Loss of appetite
• Headache
• Metallic taste
• Flatulence

How to Use

Take this medicine in the dose and duration prescribed by your doctor. Swallow it whole with water, ideally with meals. Do not crush or chew the tablet.

How It Works

Glycomet GP 2mg Tablet combines two active ingredients:

• Glimepiride (a sulfonylurea): Stimulates the pancreas to release more insulin.
• Metformin (a biguanide): Reduces liver glucose production and improves insulin sensitivity.

This combination offers better glycemic control than either drug alone, especially in people who do not respond well to monotherapy.

Frequently Asked Questions (FAQs)

References:
Glimepiride – NCBI Bookshelf
Metformin – NCBI Bookshelf
Centers for Disease Control and Prevention – Diabetes